These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 35209120)
1. Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study. Santonocito D; Vivero-Lopez M; Lauro MR; Torrisi C; Castelli F; Sarpietro MG; Puglia C Molecules; 2022 Feb; 27(4):. PubMed ID: 35209120 [TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence. Santonocito D; Barbagallo I; Distefano A; Sferrazzo G; Vivero-Lopez M; Sarpietro MG; Puglia C Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986812 [TBL] [Abstract][Full Text] [Related]
4. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
5. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer. Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559 [No Abstract] [Full Text] [Related]
7. Novel nanostructured lipid carriers loading Apigenin for anterior segment ocular pathologies. Bonilla-Vidal L; Espina M; García ML; Baldomà L; Badia J; González JA; Delgado LM; Gliszczyńska A; Souto EB; Sánchez-López E Int J Pharm; 2024 Jun; 658():124222. PubMed ID: 38735632 [TBL] [Abstract][Full Text] [Related]
8. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables. Rathod VR; Shah DA; Dave RH Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896 [TBL] [Abstract][Full Text] [Related]
9. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
10. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Mendes AI; Silva AC; Catita JA; Cerqueira F; Gabriel C; Lopes CM Colloids Surf B Biointerfaces; 2013 Nov; 111():755-63. PubMed ID: 23954816 [TBL] [Abstract][Full Text] [Related]
11. Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile. Puglia C; Santonocito D; Ostacolo C; Maria Sommella E; Campiglia P; Carbone C; Drago F; Pignatello R; Bucolo C Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32046269 [TBL] [Abstract][Full Text] [Related]
12. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Shete H; Patravale V Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345 [TBL] [Abstract][Full Text] [Related]
13. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome. Tan G; Li J; Song Y; Yu Y; Liu D; Pan W Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933 [TBL] [Abstract][Full Text] [Related]
15. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
16. Hospital wastewater treatment using eco-friendly eugenol nanostructured lipid carriers: Formulation, optimization, and in vitro study for antibacterial and antioxidant properties. Shajari M; Ahmadi N; Zamani M; Rostamizadeh K; Shapouri R Water Environ Res; 2022 Jul; 94(7):e10751. PubMed ID: 35765847 [TBL] [Abstract][Full Text] [Related]
17. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388 [TBL] [Abstract][Full Text] [Related]
18. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability. Teeranachaideekul V; Müller RH; Junyaprasert VB Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778 [TBL] [Abstract][Full Text] [Related]
20. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Soni K; Rizwanullah M; Kohli K Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]